SHENYANG, China, Feb. 11 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq:
SSRX), a leading biotechnology company focused on researching, developing,
manufacturing and marketing biopharmaceutical products primarily in China,
today announced that it has submitted its application for a Phase I cl